第一部分 奋斗历程
于金明院士简历
从农民到院士——记中国工程院院士、山东省肿瘤医院院长于金明
第二部分 学术贡献
一、于金明院士的主要学术成就与学术思想
二、于金明院士的主要学术论文
ERCCl Expression and Tumor Regression Predict Survival in Esophageal Squamous
Cell Carcinoma Patients Receiving Combined Trimodality Therapy
Repopulation of Tumor Cells During Fractionated Radiotherapy and Detection
Methods,Review)
Effect of Celecoxib on Inhibiting Tumor Repopulation During Radiotherapy in
Human FaDu Squamous Cell Carcinoma
Prognostic Significance of Epidermal Growth Factor Receptor in Locally Advanced
Esophageal Squamous Cell Carcinoma for Patients Receiving Chemoradiotherapy
Prognostic Value of 3'-Deoxy-3-18F-Fluorothymidine([18F]FLT PET)in
Patients with Recurrent Malignant gliomas☆
Progress of Radiation Oncology:Known and Unknown
Human Epidermal Growth Factor Receptor一2 Expression in Locally Advanced Rectal
Cancer:Association with Response to Neoadj uvant Therapy and Prognosis
Changes in Functional Lung Regions During the Course of Radiation Therapy and
Their Potential Impact on Lung Dosimetry for Non-Small Cell Lung Cancer
Prediction of Response to Preoperative Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer
Involved—Field Irradiation in Definitive Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
A Phase I Study of Concurrent Chemotherapy and Thoracic Radiotherapy with Oral
Epigallocateehin一3一Gallate Protection in Patients with Locally Advanced Stage HI
Non-Small-Cell Lung Cancer
Reversion of Erlotinib—Acquired Resistance Twice
by Chemotherapy A Case Report
Hypoxia Imaging with 18F—Fluoroerythronitroimidazole Integrated PET/CT and
Immunohistochemical Studies in Non—Small Cell Lung Cancer
New Strategy for Monitoring Targeted Therapy:Molecular Imaging
Cetuximab in Combination with Chemoradiotherapy in Chinese Patients with
Non-Resectable,Locally Advanced Esophageal Squamous Cell Carcinoma:
A Prospective,Multicenter Phase 1I Trail*
Mediastinal lymph Nodes Staging by 18F-FDG PET/CT for Early Stage Non—Small
Cell Lung Cancer:A Multicenter Study
Implementation of Hypoxia Measurement Into Lung Cancer TheraDv
Effect of Recombinant H uman Endostatin on Radiosensitivity in Patients with
Non-Small-Cell Lung Cancer
Imaging Proliferation of 18F-FLT PET/CT Correlated with the Expression of
Microvessel Density of Tumour Tissue in Non-Small-Cell Lung Cancer
Applications of IMAT in Cervical Esophageal Cancer RadiotheraPy:a Comparison
with Fixed—Field IMRT in Dosimetry And Implementation
Molecular Imaging with¨C—PDl53035 PET/CT Predicts Survival in Non—Small CPll
Lung Cancer Treated with EGFR—TKI:A Pilot Study
Linear Correlation Between Patient Survival and Decreased Percentage 0f TumorE 18 F]
Fluorodeoxyglucose Uptake for Late—Course Accelerated Hyperfractionated
Radiotherapy for Esophageal Cancer
Lipiodol:a Potential Direct Surrogate for Cone—Beam Computed Tomography Image
Guidance in Radiotherapy of Liver Tumor
Noninvasive Evaluation of Microscopic Tumor Extensions Using Standardized
Uptake Value and Metabolic Tumor Volume in Non-Small-Cell Lung Cancer
Measuring Tumor Hypoxia with 18F—FETNIM PET in Esophageal Squamous Cell
Carcinoma:a Pilot Clinical Study
Value of Dual—Time—Point FDG PET/CT for Mediastinal Nodal Staging in
Non-Small—Cell Lung Cancer Patients with Lung Comorbidity
Prediction of the Outcome of Definitive Chemoradiation by Decrease in
F-18 FDG Uptake in Nonsurgical Esophageal Squamous Cell Cancer
Prognostic Value of 18F—FDG PET/CT Before and After Radiotherapy for
Locally Advanced Nasopharyngeal Carcinoma
Inhibitory Effect of Radiotherapy Combined with Weekly Recombinant H uman
Endostatin on the Human Pulmonary Adenoearcinoma A549 Xenografts in Nude
Mice
Measuring Tumor Cell Proliferation with F-FLT PET During Radiotherapy of
Esophageal Squamous Cell Carcinoma:A Pilot Clinical Study
Imaging of Proliferation with 18F=FLT PET/CT Versus 18F—FDG PET/CT in
Non—Small—Cell Lung Cancer
Relationship Between Primary Lesion FDG Uptake and Clinical Stage at PET—CT
for Non—Small Cell Lung Cancer Patients:An Observation
Comparison of Tumor Volumes as Determined by Pathologic Examination and
FDG—PET/CT Images of NON=SMALL=Cell Lung Cancer:a Pilot Study
Relationship Between Primary Tumor Fluorodeoxyglucose Uptake and Nodal or
Distant Metastases at Presentation in T1 Stage Non=Small Cell Lung Cancer
Using 18F—Fluorodeoxyglucose Positron Emission Tomography to Estimate
the Length of Gross Tumor in Patients with Squamous Cell Carcinoma of the
Esophagus
Comparison of 18F-Fluorothymidine and 18F—Fluorodeoxyglucose PET/CT in
Delineating Gross Tumor Volume by Optimal Threshold in Patients with Squamous
Cell Carcinoma of Thoracic Esophagus
PET—Based Biodistribution and Radiation Dosimetry of Epidermal Growth Factor
Receptor—Selective Tracer 11C—PDl53035 in Humans
Molecular Imaging of EGFR:It's Time to Go Beyond Receptor Expression
Effects of Lentivirus——Mediated HIF——la Knockdown on Hypoxia=Related Cisplatin
Resistance and Their Dependence on p53 Status in Fibrosarcoma Cells
Value of PET/CT Versus Enhanced CT for Locoregional Lymph Nodes in Non—Small
Cell Lung Cancer☆
Assessment of 11C—labeled-4-N-(3-bromoanilino)-6,7-Dimethoxyquinazoline as a
Positron Emission Tomography Agent to Monitor Epidermal Growth Factor
Receptor Expression
Determining Optimal Clinical Target Volume Margins on The Basis of Microscopic
Extracapsular Extension of Metastatic Nodes in Patients with NON——SMALL——CELL
Lung Cancer
Diagnostic and Prognostic Value of”F=FDG PET/CT for Patients with Suspected
Recurrence from SquaITIOUS Cell Carcinoma of the Esophagus
Additional Value of PET/CT ovei‘PET in Assessment of Locoregiorlal Lymph Nodes
in Thoracic Esoplaageal SquamouIs Cell Cancer
The Pattern of Lymphatic Metastasis of Breast Caricer and Its InfllJence on The
Delineation of Radiation Fields
Flow Cytometric DNA Content and Conical Outcome in Patients with Non—Small
Cell LLmg Cancel’Given Postopm’ative Radiation Tllerapy
DNA Ploidy Analysis of Effect.iveness of Ratdiatioin Thetapy for Cervical Carcinoma
FlOW Cytometric Analysis DNA Content in Esoplaageal CarcinOlTla Correlation with
HistoloRic and Clinical Features
影像技术在放射肿瘤学中的应用
图像引导放射治疗研究及其发展
生物靶区与生物适形放疗研究进展
Ⅲ期非小细胞肺癌累及野照射的可行性研究
局部晚期非小细胞肺癌累及野照射的研究进展
调强放射治疗的临床应用现状与存在的问题
功能性影像确定肿瘤放射治疗生物靶区的研究进展
18F-脱氧葡萄糖PET用于制定肿瘤放射治疗计划研究进展
非小细胞肺癌术前肺门纵隔淋巴结CT检查和术后病理结果比较的研究
二十一世纪的放射肿瘤学
调强放射治疗研究进展,
乳腺癌淋巴结转移规律对术后放射治疗设野的影响
第三部分 治学之道
精确放疗,精确到细胞——访中华医学会放射肿瘤学分会主任委员、山东省肿瘤
医院院长、博士生导师于金明教授
科学是值得一生追求的事业一一记全国人大代表、山东省肿瘤医院院长于金明
大院士讲小故事做人做事做学问——听工程院院士、山东省肿瘤医院院长于金明
“如何做个好医生”的公开课
于金明:精确定位人生
中国工程院院士于金明:将“精确”进行到底
一个人与三个不同角色——访山东省肿瘤医院院长于金明
第四部分 大师风范
我的老师于金明
传道授业,润物无声
德医双馨——我的导师于金明
以大任为己任——我眼中的于金明导师
孜孜不倦求真知 拳拳之情育桃李——记于金明院士师门下的点滴感悟
中国工程院院士于金明:用心灵与学生对话,杏林人生满芬芳
谆谆教诲无私奉献——记我的恩师于金明院士
真的种子,善的信使,美的旗帜——学生眼中的于金明院士
“草根院士”的大医之路——我心目中的于金明院长
我心目中的于院长
大爱暖边疆——记我的导师于金明院士
大医精诚 大爱无声——致中国工程院院士于金明
大医精诚杏林春暖——我心目中的恩师于金明院士
点点滴滴是党恩
故乡的小河
第五部分 社会影响
于金明:和肿瘤细胞打一场“精确”战争
走近肿瘤放疗专家于金明教授
于金明:肿瘤放疗命中“靶心”
肿瘤斗士的老区情结——记中国工程院院士、山东省肿瘤医院院长于金明
我是来交作业的——记校友于金明院士
放疗:从未知到已知再到未知
于金明:将精确进行到底
于金明开启肿瘤治疗“精确放疗”时代
报答——2010年度山东省科学技术最高奖获得者于金明
为学科成长规划路径——山东省肿瘤医院内涵建设实践(上)
为“后生”成长培育沃土——山东省肿瘤医院内涵建设实践(下)
执大道而建奇功
于金明说防癌:减少环境污染是根本
于金明:守望麦田的医学家
于金明,“精确”对战肿瘤
“谈癌色变”大可不必——专访中国工程院院士于金明
医疗改革 任重道远——访全国人大代表 山东省肿瘤防治研究院院长于金明
防癌、抗癌需要全社会努力——中国工程院院士、山东省肿瘤医院院长于金明
谈癌症的预防和治疗
第六部分 人生风采
成长历程
勤奋工作
学术交流
重要时刻
社会责任